<DrugInformationSummary id="CDR0000814429"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about toripalimab-tpzi
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/toripalimab-tpzi">Toripalimab-tpzi</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000785704">toripalimab-tpzi</TerminologyLink><GlossaryLink ref="CDR0000814189">toripalimab</GlossaryLink><USBrandNames><USBrandName>Loqtorzi</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>TOR-ih-PA-lih-mab</TermPronunciation><MediaLink ref="CDR0000814921" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000814922" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06851535-9c74-6d6d-e063-6294a90abc76&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Toripalimab-tpzi</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06851535-9c74-6d6d-e063-6294a90abc76&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Toripalimab-tpzi
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><GlossaryTermRef href="CDR0000445072" dictionary="Cancer.gov" audience="Patient">Nasopharyngeal carcinoma</GlossaryTermRef> (a type of <GlossaryTermRef href="CDR0000257519" dictionary="Cancer.gov" audience="Patient">head and neck cancer</GlossaryTermRef>).  It is used:<ItemizedList Style="bullet" id="_4"><ListItem>With <GlossaryTermRef href="CDR0000045230" dictionary="Cancer.gov" audience="Patient">cisplatin</GlossaryTermRef> and <GlossaryTermRef href="CDR0000508951" dictionary="Cancer.gov" audience="Patient">gemcitabine hydrochloride</GlossaryTermRef> as the first treatment in adults whose cancer has spread to other parts of the body or has come back in nearby tissues.</ListItem><ListItem>Alone in adults whose cancer has come back and cannot be removed by surgery or has spread to other parts of the body and has been treated with <GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef> chemotherapy that did not work or is no longer working.</ListItem></ItemizedList></ListItem>
   </ItemizedList>
  <Para id="_5">Toripalimab-tpzi
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Toripalimab-tpzi</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785704">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-toripalimab-nasopharyngeal-cancer">Toripalimab Becomes First Immunotherapy Drug Approved for Nasopharyngeal Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors">Immune Checkpoint Inhibitors</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C131334">Find Clinical Trials for Toripalimab-tpzi</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2023-12-12</DateFirstPublished><DateLastModified>2024-01-03</DateLastModified></DrugInformationSummary>
